[1] |
王兴 . 第四次全国口腔健康流行病学调查报告[M]. 北京: 人民卫生出版社, 2018.
|
|
Wang X. Report of the fourth national epidemiological survey of oral health[M]. Beijing: People’s Medical Publishing House, 2018.
|
[2] |
Hajishengallis G . Periodontitis: from microbial immune subversion to systemic inflammation[J]. Nat Rev Immunol, 2015,15(1):30-44.
|
[3] |
Zouali M . The emerging roles of B cells as partners and targets in periodontitis[J]. Autoimmunity, 2017,50(1):61-70.
doi: 10.1080/08916934.2016.1261841
URL
|
[4] |
Cekici A, Kantarci A, Hasturk H , et al. Inflammatory and immune pathways in the pathogenesis of periodontal disease[J]. Periodontol 2000, 2014,64(1):57-80.
doi: 10.1111/prd.12002
URL
|
[5] |
Figueredo CM, Lira-Junior R, Love RM . T and B cells in periodontal disease: new functions in a complex scenario[J]. Int J Mol Sci, 2019,20(16):E3949.
|
[6] |
Sugawara M, Yamashita K, Yoshie H , et al. Detection of, and anti-collagen antibody produced by, CD5-positive B cells in inflamed gingival tissues[J]. J Periodontal Res, 1992,27(5):489-498.
doi: 10.1111/jre.1992.27.issue-5
URL
|
[7] |
Seymour GJ, Greenspan JS . The phenotypic characterization of lymphocyte subpopulations in established human periodontal disease[J]. J Periodontal Res, 1979,14(1):39-46.
|
[8] |
Berglundh T, Donati M, Zitzmann N . B cells in periodontitis? friends or enemies[J]. Periodontol 2000, 2007,45(1):51-66.
|
[9] |
Kim YC, Ko Y, Hong SD , et al. Presence of Porphyromonas gingivalis and plasma cell dominance in gingival tissues with periodontitis[J]. Oral Dis, 2010,16(4):375-381.
|
[10] |
Marjanović D, Andjelković Z, Brkić Z , et al. Quantification of mast cells in different stages of periodontal disease[J]. Vojnosanit Pregl, 2016,73(5):458-462.
doi: 10.2298/VSP141222030M
URL
|
[11] |
Coat J, Demoersman J, Beuzit S , et al. Anti-B lymphocyte immunotherapy is associated with improvement of periodontal status in subjects with rheumatoid arthritis[J]. J Clin Periodontol, 2015,42(9):817-823.
doi: 10.1111/jcpe.12433
URL
|
[12] |
Palomares O, Akdis M, Martín-Fontecha M , et al. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells[J]. Immunol Rev, 2017,278(1):219-236.
doi: 10.1111/imr.2017.278.issue-1
URL
|
[13] |
Fujiwara Y, Piemontese M, Liu Y , et al. RANKL (receptor activator of NFκB ligand) produced by osteocytes is required for the increase in B cells and bone loss caused by estrogen deficiency in mice[J]. J Biol Chem, 2016,291(48):24838-24850.
doi: 10.1074/jbc.M116.742452
URL
|
[14] |
Kuritani M, Sakai N, Karakawa A , et al. Anti-mouse RANKL antibodies inhibit alveolar bone destruction in periodontitis model mice[J]. Biol Pharm Bull, 2018,41(4):637-643.
|
[15] |
Tonetti MS, Henry G, Kornman KS . Staging and grading of periodontitis: framework and proposal of a new classification and case definition[J]. J Periodontol, 2018,89:S159-S172.
doi: 10.1002/JPER.18-0006
URL
|
[16] |
Chapple Iain LC, Mealey Brian L, Van Dyke Thomas E , et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions[J]. J Clin Periodontol, 2018,45:S68-S77.
doi: 10.1111/jcpe.2018.45.issue-S20
URL
|
[17] |
Rathod S, Raj A, Wanikar I . Quantitative analysis of mast cell count and density in chronic periodontal disease[J]. J Indian Soc Periodontol, 2018,22(2):107-111.
doi: 10.4103/jisp.jisp_3_18
URL
|
[18] |
Moore PA, Belvedere O, Orr A , et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator[J]. Science, 1999,285(5425):260-263.
doi: 10.1126/science.285.5425.260
URL
|
[19] |
Han YK, Jin Y, Miao YB , et al. Improved RANKL production by memory B cells: a way for B cells promote alveolar bone destruction during periodontitis[J]. Int Immunopharmacol, 2018,64:232-237.
doi: 10.1016/j.intimp.2018.08.033
URL
|
[20] |
Belibasakis GN, Bostanci N . The RANKL-OPG system in clinical periodontology[J]. J Clin Periodontol, 2012,39(3):239-248.
doi: 10.1111/j.1600-051X.2011.01810.x
URL
|
[21] |
Kim HR, Lee SH, Kim HY , et al. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS)[J]. Rheumatology (Oxford), 2006,45(10):1197-1200.
doi: 10.1093/rheumatology/kel072
URL
|